SR biotek Inc. (XKON:270210)

New Relic Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2016	FY 2015
Period Ending	Dec 31, 2016	Dec 31, 2015
Cash & Equivalents	257.35	462.13
Short-Term Investments	101.8	1.2
Cash & Short-Term Investments	359.15	463.33
Cash Growth	-22.48%	-
Accounts Receivable	28.38	3.36
Other Receivables	1.16	0.27
Receivables	38.75	3.63
Inventory	266.93	320.49
Prepaid Expenses	0.74	-
Other Current Assets	8.99	26.5
Total Current Assets	674.55	813.95
Property, Plant & Equipment	1,868	1,982
Other Intangible Assets	0.65	0.44
Other Long-Term Assets	3.81	7.1
Total Assets	2,547	2,804
Accounts Payable	30.41	42.43
Accrued Expenses	44.44	57.64
Current Portion of Long-Term Debt	779	461.25
Current Income Taxes Payable	2.43	6.89
Other Current Liabilities	6.87	78.47
Total Current Liabilities	863.15	646.68
Long-Term Debt	933.75	1,372
Other Long-Term Liabilities	0	-
Total Liabilities	2,003	2,183
Common Stock	200	200
Retained Earnings	344.07	421.05
Shareholders' Equity	544.07	621.05
Total Liabilities & Equity	2,547	2,804
Total Debt	1,713	1,833
Net Cash (Debt)	-1,354	-1,370
Net Cash Per Share	-33834.13	-34243.71
Filing Date Shares Outstanding	0.04	0.04
Total Common Shares Outstanding	0.04	0.04
Working Capital	-188.6	167.27
Book Value Per Share	13599.45	15526.66
Tangible Book Value	543.42	620.62
Tangible Book Value Per Share	13583.15	15515.79
Land	350.02	350.02
Buildings	1,058	1,058
Machinery	678.6	545.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.